Goal & condition hub · Women 40-55

Metabolic health & weight

Body composition and metabolic health shift in midlife, and peptides are an area of growing curiosity here. Some have strong, approved human evidence; others are far more speculative. This hub gathers them and keeps that difference clear and easy to follow.

Peptides studied for this goal

Each links to its full profile, where evidence is rated and sourced.

Strong (human) Growth Hormone Axis

Tesamorelin

Tesamorelin (trans-3-hexenoyl GHRH 1-44)

Tesamorelin is a lab-made version of a natural hormone (GHRH) that nudges the body to release its own growth hormone. Unlike most research peptides, it is FDA-approved, for reducing excess belly fat in people with HIV-associated lipodystrophy, and that approval is backed by large, randomized human trials. Evidence for other uses, such as cognition, is far more preliminary.

Read profile

Key studies

Randomized controlled trial New England Journal of Medicine · 2010
Tesamorelin for reduction of visceral adipose tissue in HIV-associated lipodystrophy
In this randomized, placebo-controlled trial, participants receiving tesamorelin had a measurable reduction in visceral adipose tissue compared with placebo over the study period. The trial was conducted in a specific HIV population, and results may not generalize to other groups.

Category Metabolic & GLP-1